爱德士 IDXX 深 沪
等待开盘 08-28 09:30:00 美东时间
545.08
-8.360
-1.51%
华盛通- 最 高553.11
- 今 开549.73
- 成交量 34.06万股
- 最 低 542.01
- 昨 收 553.44
- 总市值 429.42亿
- 52周最高 769.98
- 市盈率 静 41.69
- 换手率 0.43%
- 52周最低 518.55
- 委 比 -85.42%
- 总股本 7878.11万
- 历史最高 769.98
- 量 比 0.77
- 振 幅 2.01%
- 历史最低 31.915
- 每 手 1
- 风险率 59.82%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅207.38%！Truist Securities上调AbCellera Biologics目标价至30美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持AbCellera Biologics"买入"评级，目标价从12美元升至30美元；Stifel：维持Proficient Auto Logistics"买入"评级，目标价从9美元升至12美元
08-12 08:45
Barclays Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $710
Barclays analyst Glen Santangelo maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and lowers the price target from $800 to $710.
08-11 21:51
美股大行评级 | AMD、Arista Networks、Booking 、加特纳、Pinterest、科力斯、Wayfair等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Precigen"买入"评级，目标价从14美元升至18美元；HC Wainwright & Co.：维持Sophia Genetics"买入"评级，目标价从12美元升至14美元
08-06 11:36
财报速睇 | 爱德士 2026财年Q2营收12.17亿美元，同比增长9.7%；归母净利润3.38亿美元，同比增长15.1%
华盛资讯8月5日讯，爱德士公布2026财年Q2业绩，公司Q2营收12.17亿美元，同比增长9.7%，归母净利润3.38亿美元，同比增长15.1%。
08-05 07:35
Why Is IDEXX Laboratories Stock Gaining Tuesday?
IDEXX Laboratories, Inc. (NASDAQ:IDXX) stock rose Tuesday after the veterinary diagnostics company reported second-quarter results that topped Wall Street estimates and raised its full-year earnings outlook. Companion Animal Diagnostics Fuel Growth The company reported second-quarter earnings of $4....
08-04 23:39
IDEXX Laboratories shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 GAAP EPS guidance above estimates.
IDEXX Laboratories shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 GAAP EPS guidance above estimates.
08-04 19:46
财报速睇 | 爱德士 2026财年Q2营收12.17亿美元，同比增长9.7%；归母净利润4.26亿美元，同比增长14.2%
华盛资讯8月4日讯，爱德士公布2026财年Q2业绩，公司Q2营收12.17亿美元，同比增长9.7%，归母净利润4.26亿美元，同比增长14.2%。
08-04 19:01
美股大行评级 | ITG、Bending Spoons获多家大行首予买入评级；瑞银下调微软目标价从510美元降至480美元
今日重点评级关注：BTIG：上调Outlook Therapeutics"买入"评级，目标价4美元；TD Cowen：维持Nakamoto"买入"评级，目标价从1美元升至17美元
07-28 11:34
UBS Maintains Neutral on IDEXX Laboratories, Lowers Price Target to $620
UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers the price target from $640 to $620.
07-28 02:08
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 10 years by 6.72% on an annualized basis producing an average annual return of 20.38%. Currently, IDEXX Laboratories has a market capitalization of $45.20 billion. Buying $100 In IDXX: If an investor had bought $100 of IDXX s...
06-17 06:01
